MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

Five-Fold VTE Risk Seen with Corticosteroids for IBD

Newly released study results suggest that corticosteroid therapy is associated with a nearly five-fold increase of venous venous thromboembolism (VTE) in patients with inflammatory bowel disease (IBD) compared to treatment with a biologic agent.

Nutrition Plays Key Role in Mental Health, Argues Study

A new international collaboration published in The Lancet Psychiatry is encouraging the fields of psychiatry and public health to recognize the relationships between diet quality, potential nutritional deficiencies, and mental health.

Single Access Heart Pump OK'd for Right Heart Support

Abiomed announced that the Food and Drug Administration (FDA) has approved the Impella Right Percutaneous System under a Humanitarian Device Exemption (HDE).

Eye-Tracking Tool Promising for Concussion, Brain Injury Diagnosis

Researchers at NYU Langone Medical Center have developed a unique diagnostic tool for concussion or brain injury that can be utilized in the emergency room, and potentially on the sidelines at sporting events.

ADHD Linked to Earlier Substance Abuse, HIV-Risk Behaviors

A history of attention deficit hyperactivity disorder (ADHD) in adults is significantly associated with younger ages of initiation for illicit substance use and a greater risk of engagement in recent HIV-risk behaviors such as injection drug use and needle sharing, suggests a new article in the journal Addictive Behaviors.